# First in Human Study of NI-0701 in Healthy Volunteers

> **NCT01255501** · PHASE1 · COMPLETED · sponsor: **Light Chain Bioscience - Novimmune SA**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** NI-0701
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01255501
- **Lead sponsor:** Light Chain Bioscience - Novimmune SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01255501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01255501, "First in Human Study of NI-0701 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01255501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*